Julia Marie Eastland Zentalis Pharmaceuticals, Inc. (ZNTL) insider trading activity

ZNTL Quotes by TradingView

Julia Marie Eastland is CEO & President of Zentalis Pharmaceuticals, Inc.. Currently has a direct ownership of 87,888 shares of ZNTL, which is worth approximately $181,928. The most recent transaction as insider was on Feb 03, 2025, when has been sold 59,388 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 87.9K
n/a 3M change
n/a 12M change
Total Value Held $181,928

JULIA MARIE EASTLAND Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 03 2025
BUY
Grant, award, or other acquisition
-
59,388 Added 40.32%
87,888 Common Stock
Jan 31 2025
BUY
Open market or private purchase
$49,305 $1.73 p/Share
28,500 Added 50.0%
28,500 Common Stock

Also insider at

HARP
Harpoon Therapeutics, Inc. Healthcare
President and CEO
DVAX
DYNAVAX TECHNOLOGIES CORP Healthcare
GRAY
GRAYBUG VISION, INC. Healthcare
Director
LNTH
Lantheus Holdings, Inc. Healthcare
Director
JME

Julia Marie Eastland

CEO & President
Emeryville, CA

Track Institutional and Insider Activities on ZNTL

Follow Zentalis Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ZNTL shares.

Notify only if

Insider Trading

Get notified when an Zentalis Pharmaceuticals, Inc. insider buys or sells ZNTL shares.

Notify only if

News

Receive news related to Zentalis Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ZNTL